Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
AI-Driven Wellness Play on the CSE (click to learn more) Golden Cariboo (CSE:GCC) (OTC:GCCFF) Unlocks Cariboo Gold Potential (click to learn more) An Emerging Name in Cannabis: HERB (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Lonza Group AG Zuerich Namen AKT (PK) LZAGF

Alternate Symbol(s):  LZAGY

Healthcare Drug Manufacturers - Specialty & Generic
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract... see more

Current News (PINL:LZAGF)

NeuroSense Announces First Quarter 2024 Business Update

PR Newswire May 2, 2024

IsoPlexis and Lonza Collaborate to Enable the Next Generation of Precision Cell Therapy Manufacturing

PR Newswire August 20, 2020

Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy

PR Newswire November 5, 2019

Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in Canada

Canada NewsWire December 21, 2018

Lonza Opens World's Largest Dedicated Cell and-Gene-Therapy Manufacturing Facility in Pearland, Greater Houston, TX (USA)

PR Newswire April 10, 2018

Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries

PR Newswire December 15, 2016

Lonza to Divest Peptides Business and Operations in Braine-l'Alleud, Belgium, to PolyPeptide

Stockhouse Editorial December 7, 2016

Kalobios (KBIO) seeks bankruptcy protection following Shkreli arrest

Canadian Press December 30, 2015

Lonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi Therapeutics

PR Newswire October 7, 2015
View More News ››

Opinion & Analysis (PINL:LZAGF)

Companies flocking to Japan for biotech deals

The Life Sciences Report February 2, 2017

Regenerative medicine in Japan: CJ PARTNERS' Colin Lee Novick ATHX, RP, RGS, 7774:TYO, 4527:TYO, 2372:TYO

Gail Dutton August 5, 2015
View More Opinion ››

Bullboard Posts (PINL:LZAGF)

Enteric Softgel Capsules Market Analysis Size Report 2022-27

According to the latest report by IMARC Group, titled “Enteric Softgel Capsules Market: Global Industry Trends, Share, Size, Growth...
johnson021 - September 12, 2022
View more Bullboard ››

Equity Metals Corp.

Equity Metals Corp.

Equity Metals Corporation engages in the acquisition, exploration, and development of mineral and diamond properties in ...
View More »

Podcasts